Therini Bio, Inc.
Katerina Akassoglou is the Director for the Center for Neurovascular Brain Immunology at Gladstone & UCSF, as well as a Senior Investigator and Director for the Center for In Vivo Imaging Research. Katerina is also a Professor of Neurology at UCSF and the Founder of Therini Bio, Inc. Prior to their current roles, Katerina held positions at the University of California San Diego, New York University, Rockefeller University, and Stony Brook University. Akassoglou holds a Doctor of Philosophy in Neuroimmunology and has a strong background in pharmacology and neurology.
This person is not in any teams
Therini Bio, Inc.
Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction. Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications. The current therapeutic target is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation.